Cormorant Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $13.1M | Sell |
|
|||||
|
2021
Q3 | $27M | Sell |
|
|||||
|
2021
Q2 | $35.1M | Hold |
|
|||||
|
2021
Q1 | $50.4M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $270K | Hold |
|
|||||
|
2019
Q2 | $548K | Sell |
|
|||||
|
2019
Q1 | $2.52M | Sell |
|
|||||
|
2018
Q4 | $3.53M | Sell |
|
|||||
|
2018
Q3 | $7.26M | Sell |
|
|||||
|
2018
Q2 | $10.5M | Hold |
|
|||||
|
2018
Q1 | $9.21M | Sell |
|
|||||
|
2017
Q4 | $13.6M | Hold |
|
|||||
|
2017
Q3 | $14.2M | Sell |
|
|||||
|
2017
Q2 | $19.5M | Sell |
|
|||||
|
2017
Q1 | $23.9M | Sell |
|
|||||
|
2016
Q4 | $26.5M | Buy |
|
|||||
|
2016
Q3 | $23.1M | Hold |
|
|||||
|
2016
Q2 | $16.6M | Buy |
|
|||||
|
2016
Q1 | $12.3M | Hold |
|
|||||
|
2015
Q4 | $17.5M | Buy |
|